165 related articles for article (PubMed ID: 22366825)
1. Safety of recombinant human deoxyribonuclease as a rescue treatment for persistent atelectasis in newborns.
Fedakar A; Aydogdu C; Fedakar A; Ugurlucan M; Bolu S; Iskender M
Ann Saudi Med; 2012; 32(2):131-6. PubMed ID: 22366825
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of nebulized recombinant human DNase as rescue treatment for persistent atelectasis in newborns: case-series.
Erdeve O; Uras N; Atasay B; Arsan S
Croat Med J; 2007 Apr; 48(2):234-9. PubMed ID: 17436388
[TBL] [Abstract][Full Text] [Related]
3. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns.
Dilmen U; Karagol BS; Oguz SS
Pediatr Int; 2011 Jun; 53(3):328-31. PubMed ID: 20831650
[TBL] [Abstract][Full Text] [Related]
4. Comparing the efficacy of nebulizer recombinant human DNase and hypertonic saline as monotherapy and combined treatment in the treatment of persistent atelectasis in mechanically ventilated newborns.
Altunhan H; Annagür A; Pekcan S; Ors R; Koç H
Pediatr Int; 2012 Feb; 54(1):131-6. PubMed ID: 22114907
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human deoxyribonuclease improves atelectasis in mechanically ventilated children with cardiac disease.
Prodhan P; Greenberg B; Bhutta AT; Hyde C; Vankatesan A; Imamura M; Jaquiss RD; Dyamenahalli U
Congenit Heart Dis; 2009; 4(3):166-73. PubMed ID: 19489944
[TBL] [Abstract][Full Text] [Related]
6. Resolution of mucus plugging and atelectasis after intratracheal rhDNase therapy in a mechanically ventilated child with refractory status asthmaticus.
Durward A; Forte V; Shemie SD
Crit Care Med; 2000 Feb; 28(2):560-2. PubMed ID: 10708200
[TBL] [Abstract][Full Text] [Related]
7. Bronchoscopically administered recombinant human DNase for lobar atelectasis in cystic fibrosis.
Slattery DM; Waltz DA; Denham B; O'Mahony M; Greally P
Pediatr Pulmonol; 2001 May; 31(5):383-8. PubMed ID: 11340685
[TBL] [Abstract][Full Text] [Related]
8. Clinical and in vitro effect of dornase alfa in mechanically ventilated pediatric non-cystic fibrosis patients with atelectases.
Riethmueller J; Kumpf M; Borth-Bruhns T; Brehm W; Wiskirchen J; Sieverding L; Ankele C; Hofbeck M; Baden W
Cell Physiol Biochem; 2009; 23(1-3):205-10. PubMed ID: 19255515
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of atelectasis with Dornase alpha in a patient with congenital muscular dystrophy.
Crescimanno G; Marrone O
Rev Port Pneumol; 2014; 20(1):42-5. PubMed ID: 24095150
[TBL] [Abstract][Full Text] [Related]
10. DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis.
Merkus PJ; de Hoog M; van Gent R; de Jongste JC
Eur Respir J; 2001 Oct; 18(4):734-7. PubMed ID: 11716180
[TBL] [Abstract][Full Text] [Related]
11. Rescue use of DNase in critical lung atelectasis and mucus retention in premature neonates.
El Hassan NO; Chess PR; Huysman MW; Merkus PJ; de Jongste JC
Pediatrics; 2001 Aug; 108(2):468-70. PubMed ID: 11483817
[TBL] [Abstract][Full Text] [Related]
12. DNase and atelectasis in non-cystic fibrosis pediatric patients.
Hendriks T; de Hoog M; Lequin MH; Devos AS; Merkus PJ
Crit Care; 2005 Aug; 9(4):R351-6. PubMed ID: 16137347
[TBL] [Abstract][Full Text] [Related]
13. Inhaled Dornase alfa (Pulmozyme) as a noninvasive treatment of atelectasis in mechanically ventilated patients.
Zitter JN; Maldjian P; Brimacombe M; Fennelly KP
J Crit Care; 2013 Apr; 28(2):218.e1-7. PubMed ID: 23266402
[TBL] [Abstract][Full Text] [Related]
14. Treatment of lobar atelectasis with bronchoscopically administered recombinant human deoxyribonuclease in cystic fibrosis?
McLaughlin AM; McGrath E; Barry R; Egan JJ; Gallagher CG
Clin Respir J; 2008 Apr; 2(2):123-6. PubMed ID: 20298317
[TBL] [Abstract][Full Text] [Related]
15. Dornase alpha compared to hypertonic saline for lung atelectasis in critically ill patients.
Youness HA; Mathews K; Elya MK; Kinasewitz GT; Keddissi JI
J Aerosol Med Pulm Drug Deliv; 2012 Dec; 25(6):342-8. PubMed ID: 22413805
[TBL] [Abstract][Full Text] [Related]
16. Nebulised deoxyribonuclease for viral bronchiolitis in children younger than 24 months.
Enriquez A; Chu IW; Mellis C; Lin WY
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD008395. PubMed ID: 23152257
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant human DNase in a premature infant with recurrent atelectasis.
Küpeli S; Teksam O; Dogru D; Yurdakök M
Pediatr Int; 2003 Oct; 45(5):584-6. PubMed ID: 14521538
[No Abstract] [Full Text] [Related]
18. Use of recombinant human deoxyribonuclease in pediatric intensive care unit - a single-center experience.
Meireles D; Fernandes SR; Sarmento A; Barbosa T; Magalhães MF; Ramos A; Fernandes PC
Rev Paul Pediatr; 2021; 40():e2020169. PubMed ID: 34495270
[TBL] [Abstract][Full Text] [Related]
19. The use of dornase alpha for post-operative pulmonary atelectasis after congenital heart surgery.
Ozturk E; Tanidir IC; Haydin S; Onan IS; Odemis E; Bakir I
Cardiol Young; 2014 Oct; 24(5):807-12. PubMed ID: 23915544
[TBL] [Abstract][Full Text] [Related]
20. Endotracheal DNase for atelectasis in ventilated neonates.
MacKinnon R; Wheeler KI; Sokol J
J Perinatol; 2011 Dec; 31(12):799-801. PubMed ID: 22124516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
